GRI Bio Inc (NAS:GRI)
$ 0.358 -0.0183 (-4.86%) Market Cap: 1.05 Mil Enterprise Value: -5.16 Mil PE Ratio: 0 PB Ratio: 0.06 GF Score: 21/100

Vallon Pharmaceuticals Inc at JTC Team Top Picks Virtual Investor Conference Transcript

Jan 25, 2022 / 02:00PM GMT
Jenene Thomas
JTC Team, LLC - IR

Good morning, and thank you all for joining us for the Virtual Investor Conference. My name is Jenene Thomas. I am CEO of JTC IR, and I will be the moderator for today's event. We actually have an exciting line-up over the next three days. The conference runs today, tomorrow and Thursday. So please check our website at virtualinvestorco.com for the latest schedule.

For our first presentation today, I'm pleased to be joined by David Baker, President and CEO of Vallon Pharmaceuticals. Welcome, David.

David Baker
Vallon Pharmaceuticals, Inc. - President & CEO

Thank you, Jenene. And good morning.

Jenene Thomas
JTC Team, LLC - IR

Good morning. It's great to have you back on the platform. It has been almost a year. We're approaching your one-year anniversary for your becoming a publicly listed company. So congratulations on that.

David Baker;Jenene
Vallon Pharmaceuticals, Inc. - President & CEO

Thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot